Can you take tirzepatide or semaglutide while breastfeeding?
The labels differ by medicine and country. For tirzepatide (Mounjaro, Zepbound), a small single-dose study found little or none in breast milk, and EU and UK labels say it could be considered. The EU, UK, Australian and Canadian labels for semaglutide (Ozempic, Wegovy) say not to use it while breastfeeding. Effects on babies and milk supply are unstudied.
What do the labels say about tirzepatide while breastfeeding?
The EU and UK labels say tirzepatide could be considered while breastfeeding. The US, Canadian and Australian labels ask for benefits and risks to be weighed.1,2,5,8,11,14,15
The US Zepbound and Mounjaro labels describe one study. Eleven breastfeeding women each had a single 5 mg dose. Tirzepatide could not be detected in 164 of 171 milk samples.1,2 The total found was under 0.02% of the mother’s dose.1,2
The US labels say there are no data on effects on the breastfed baby or on milk production. They ask for the benefits of breastfeeding to be weighed against the mother’s need and any effects on the baby.1,2 The Canadian Zepbound and Mounjaro monographs use the same wording.14,15
The EU and UK labels add that tirzepatide is built from amino acids. Any small amount in milk is expected to be broken down, not absorbed whole by the baby.5,8 The Australian label says to use it while nursing only if the benefit to the mother justifies the risk to the baby.11 The NHS tirzepatide page says it is not used while breastfeeding.18
What do the labels say about semaglutide while breastfeeding?
Outside the US, every semaglutide label we checked says not to use it while breastfeeding. The Canadian Wegovy monograph lists breastfeeding as a reason not to use it (a contraindication).6,7,9,10,12,13,16,17
The EU, UK and Australian Wegovy labels note that semaglutide passed into milk in rats. They say a risk to the baby cannot be ruled out.6,9,12 The NHS semaglutide page also says it is not used while breastfeeding.19
The US Wegovy and Ozempic labels say there are no data on injected semaglutide in human milk, the baby or milk production. They ask for the same weighing of benefits and risks.3,4
Tablets are treated differently. In a study of semaglutide tablets, semaglutide in milk was too low to measure, but the tablets’ absorption helper (SNAC) was found.3 The US label advises against breastfeeding on Wegovy tablets, because SNAC could build up in babies.3 The EU Wegovy label also says SNAC passes into milk.6
What does research show about breast milk and milk supply?
One small study found no injected semaglutide in breast milk. No study we found measured milk supply or followed breastfed babies over time.20,1
The 2024 study tested milk from 8 women taking 0.25 mg to 1 mg of semaglutide a week. Semaglutide was not detected in any sample.20 The authors estimated a baby would get at most 1.26% of the mother’s dose, adjusted for weight. They called this far below the usual 10% safety threshold.20
The authors said 8 women is too few to be sure the results apply widely. They did not measure milk production or what the milk contained.20 The US Zepbound label also has no data on milk production.1 The EU and UK Mounjaro labels say it is not known whether eating less on tirzepatide changes what is in breast milk.5,8
What do people on GLP‑1 medicines report about breastfeeding?
From public patient forums: 81 Reddit threads in r/Zepbound, r/mounjarouk, r/Semaglutide, r/Mounjaro, r/Ozempic and r/WegovyWeightLoss, read from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the label Many weaned or stopped pumping before starting, or are waiting to. Outside the US, the semaglutide labels say not to use it while breastfeeding.6,9,12,16
- Matches the label Many say little of the medicine reaches milk, and worry more about supply and their own eating. In the tirzepatide label study, most milk samples had none detectable.1
- Matches the NHS Many say a prescriber or pharmacy refused, or asked them to wean first. The NHS pages say neither medicine is used while breastfeeding.18,19
- Not studied Several used one while breastfeeding, mostly with older babies eating solids, and saw no problems. The US labels have no data on effects on breastfed babies.1,3
- Not studied Several report a drop in milk supply, often linked to eating less. A few say supply rose. We found no study of supply on these medicines.
Advice people share
- Matches the NHS Many advise telling every prescriber about breastfeeding. The NHS pages say to tell your doctor if you’re breastfeeding.18,19
- Not studied Many suggest keeping up food, protein and fluids to protect supply. We found no study of this on these medicines.
- Label says otherwise Several replies say the medicine cannot reach milk or is fine for babies. The US Zepbound label found small amounts in 7 of 171 samples, and has no data on babies.1
- Label says otherwise Several posts describe improvised doses, such as partial pen doses or self-chosen “microdoses”. The US Zepbound label gives set doses, injected once a week.1
In your country
Every label we checked says human data are limited or missing. What differs is whether tirzepatide could be considered and whether semaglutide is ruled out.1,5,6,11,16
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: The Australian Mounjaro label says to use tirzepatide while nursing only if the benefit to the mother justifies the risk to the baby. It does not say it could be considered.11 The Australian Wegovy and Ozempic labels say semaglutide should not be used while breastfeeding.12,13
Emergency number: 000
Should I consider a GLP‑1 medicine? And when not to (Australia)
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: The Zepbound and Mounjaro monographs ask for benefits and risks to be weighed, as the US labels do.14,15 The Wegovy monograph lists breastfeeding as a contraindication, and the Ozempic patient information says not to use it while breastfeeding.16,17
Emergency number: 911
Should I consider a GLP‑1 medicine? And when not to (Canada)
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The answer above applies.
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies.
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We found no public Indian label to open, so this page relies on the US, EU, UK, Australian and Canadian labels. The Endocrine Society of India’s 2025 obesity guideline lists pregnancy and breastfeeding as a contraindication for tirzepatide.21
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a Saudi label for this page, so it relies on the US, EU, UK, Australian and Canadian labels, which differ as described above.1,5,6
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a UAE label for this page, so it relies on the US, EU, UK, Australian and Canadian labels, which differ as described above.1,5,6
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK Mounjaro label says tirzepatide could be considered while breastfeeding, but the NHS tirzepatide page says it is not used while breastfeeding.8,18
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The US labels do not rule out injected semaglutide while breastfeeding. They ask for benefits and risks to be weighed for both medicines.1,3,4 They advise against breastfeeding on Wegovy tablets.3
Emergency number: 911
Contact your prescriber or a doctor right away if your baby has fewer wet nappies than usual, few or no tears when crying, a sunken soft spot on the head, or seems drowsy. The NHS lists these as signs of dehydration that need urgent help. The same applies if you feel dizzy on standing and it does not pass, or have dark yellow pee or are peeing less than normal.22
Read the full picture
Related questions
Sources
- Eli Lilly. Zepbound (tirzepatide) US prescribing information. Sections 2.1 and 8.2. pi.lilly.com
- Eli Lilly. Mounjaro (tirzepatide) US prescribing information. Section 8.2. pi.lilly.com
- Novo Nordisk. Wegovy (semaglutide) US prescribing information and Medication Guide. Sections 8.2 and 17. novo-pi.com
- Novo Nordisk. Ozempic (semaglutide) US prescribing information and Medication Guide. Section 8.2. novo-pi.com
- European Medicines Agency. Mounjaro summary of product characteristics (EU label), section 4.6. ema.europa.eu
- European Medicines Agency. Wegovy summary of product characteristics (EU label), section 4.6. ema.europa.eu
- European Medicines Agency. Ozempic summary of product characteristics (EU label), section 4.6. ema.europa.eu
- Mounjaro KwikPen summary of product characteristics (UK label), section 4.6. medicines.org.uk
- Wegovy 2.4 mg FlexTouch summary of product characteristics (UK label), section 4.6. medicines.org.uk
- Ozempic 1 mg summary of product characteristics (UK label), section 4.6. medicines.org.uk
- Mounjaro Australian Product Information, section 4.6. medsinfo.com.au
- Wegovy Australian Product Information, section 4.6. medsinfo.com.au
- Ozempic Australian Product Information, section 4.6. medsinfo.com.au
- Zepbound (tirzepatide injection) Canadian Product Monograph, section 7.1.2. pdf.hres.ca
- Mounjaro (tirzepatide injection) Canadian Product Monograph, section 7.1.2. pdf.hres.ca
- Wegovy (semaglutide injection) Canadian Product Monograph, contraindications and section 7.1.2. pdf.hres.ca
- Ozempic (semaglutide injection) Canadian Product Monograph, patient medication information. pdf.hres.ca
- NHS. Tirzepatide. nhs.uk
- NHS. Semaglutide. nhs.uk
- Diab H, Fuquay T, Datta P, et al. Subcutaneous semaglutide during breastfeeding: infant safety regarding drug transfer into human milk. Nutrients, 2024. pmc.ncbi.nlm.nih.gov
- Endocrine Society of India. ESI clinical practice guidelines for the evaluation and management of obesity in India: an update (2025), Table 1. pmc.ncbi.nlm.nih.gov
- NHS. Dehydration. nhs.uk
- American College of Emergency Physicians. Know When to Go. emergencyphysicians.org
Last checked Nov 16, 2026 · Next review due Nov 16, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked between Nov 9 and Nov 16, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write